HTR1A and sexual dysfunction: The present concept of an ‘on-demand’ inhibitor of premature ejaculation, adding a behaviorally silent 5-HT1A-receptor antagonist to an acute dose of an SSRI that on itself does not have inhibitory action on male rat sexual behavior illustrates the possibility to develop new approaches in treatment of sexual dysfunctions, in this case lifelong premature ejaculation.